Published in J Clin Invest on November 01, 1989
A review and current perspective on Wilson disease. J Clin Exp Hepatol (2013) 1.15
Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J Clin Invest (1991) 1.10
Antibacterial and Biocompatible Titanium-Copper Oxide Coating May Be a Potential Strategy to Reduce Periprosthetic Infection: An In Vitro Study. Clin Orthop Relat Res (2017) 0.85
Zinc uptake and storage: the role of fundus pigmentation. Graefes Arch Clin Exp Ophthalmol (2005) 0.79
Iron, hepcidin, and the metal connection. Front Pharmacol (2014) 0.78
Longitudinal analysis of serum miR-122 in a rat model of Wilson's disease. Hepatol Int (2012) 0.78
The effect of zinc and D-penicillamine in a stable human hepatoma ATP7B knockout cell line. PLoS One (2014) 0.76
Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease. J Cell Mol Med (2015) 0.75
Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines. World J Gastroenterol (2016) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science (1980) 13.44
CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY. Methods Med Res (1964) 5.87
Glutathione metabolism and its selective modification. J Biol Chem (1988) 4.89
The sequence of human serum albumin cDNA and its expression in E. coli. Nucleic Acids Res (1981) 2.97
Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev (1985) 2.66
The role of glutathione in copper metabolism and toxicity. J Biol Chem (1989) 1.91
Copper and the liver. Gastroenterology (1980) 1.50
Induction of metallothionein-I mRNA in cultured cells by heavy metals and iodoacetate: evidence for gratuitous inducers. Mol Cell Biol (1984) 1.37
Chromosomal location of human metallothionein genes: implications for Menkes' disease. Science (1984) 1.26
Clinical, morphologic, and chemical studies on copper toxicosis of Bedlington Terriers. J Am Vet Med Assoc (1979) 1.16
Influence of cytosolic pH on receptor-mediated endocytosis of asialoorosomucoid. Am J Physiol (1988) 1.12
Morphologic and chemical studies on a murine mutation (toxic milk mice) resulting in hepatic copper toxicosis. Lab Invest (1988) 1.06
Inhibition of rabbit reticulocyte lysate protein synthesis by heavy metal ions involves the phosphorylation of the alpha-subunit of the eukaryotic initiation factor 2. J Biol Chem (1987) 1.06
Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients. J Neurol Sci (1987) 1.01
Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration). Lab Invest (1987) 0.97
Hepatic lysosomal copper protein in dogs with an inherited copper toxicosis. Hepatology (1981) 0.96
Fluorescent thiol reagents. V. Microfluorometry of thiol compounds with a fluorescent-labeled maleimide. Anal Biochem (1972) 0.95
Electron probe X-ray analysis on human hepatocellular lysosomes with copper deposits: copper binding to a thiol-protein in lysosomes. Lab Invest (1984) 0.95
Increased type I procollagen mRNA levels and in vitro protein synthesis in the baboon model of chronic alcoholic liver disease. Gastroenterology (1985) 0.95
Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens. Hepatology (1987) 0.88
Resistance to copper toxicity of cultured hepatoma cells. Characterization of resistant cell lines. J Biol Chem (1986) 0.87
Transport and intracellular distribution of copper in a human hepatoblastoma cell line, HepG2. Hepatology (1986) 0.82
Canine hepatic lysosomal copper protein: identification as metallothionein. Arch Biochem Biophys (1985) 0.82
Immunohistochemical demonstration of the cytoplasmic copper-associated protein in the liver in primary biliary cirrhosis: its identification as metallothionein. Liver (1984) 0.79
Copper as a dissociating agent of liver and endometrial polysomes. Fertil Steril (1974) 0.78
A copper-sulfur complex in the liver of a patient with Wilson's disease. Gastroenterol Jpn (1986) 0.78
The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins. J Biol Chem (1974) 4.57
The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem (1971) 3.73
D-penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med (1975) 2.56
In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis. J Cell Biol (1989) 2.47
Prevention of Wilson's disease in asymptomatic patients. N Engl J Med (1968) 2.11
The existence of a second route for the transfer of certain glycoproteins from the circulation into the liver. Biochem Biophys Res Commun (1976) 1.87
Physical and chemical studies on ceruloplasmin. IV. Preparation of radioactive, sialic acid-free ceruloplasmin labeled with tritium on terminal D-galactose residues. J Biol Chem (1966) 1.84
Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proc Natl Acad Sci U S A (1987) 1.82
Regulation of lipid stores and metabolism by lipophagy. Cell Death Differ (2012) 1.80
Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J Biol Chem (1968) 1.80
Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet (1997) 1.79
Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol (2000) 1.72
Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology (1999) 1.71
Decreased taste sensitivity after D-penicillamine reversed by copper administration. Lancet (1967) 1.69
Increased transforming growth factor-beta 1 gene expression in human liver disease. J Hepatol (1992) 1.64
Chronic hepatitis as a first manifestation of Wilson's disease. Ann Intern Med (1972) 1.64
NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am J Physiol (1998) 1.63
Orthotopic liver transplantation for Wilson's disease. Lancet (1971) 1.60
The peroxisomes of human hepatocytes. Lab Invest (1977) 1.50
Copper and the liver. Gastroenterology (1980) 1.50
THE INCORPORATION OF COPPER INTO CERULOPLASMIN IN VIVO: STUDIES WITH COPPER AND COPPER. J Clin Invest (1961) 1.48
Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology (1989) 1.47
Catabolism of desialylated ceruloplasmin in the liver. J Biol Chem (1970) 1.47
Physical and chemical studies on ceruloplasmin. IX. The role of galactosyl residues in the clearance of ceruloplasmin from the circulation. J Biol Chem (1970) 1.47
A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol (1997) 1.44
Is non-Indian childhood cirrhosis caused by excess dietary copper? Lancet (1994) 1.43
Endocytosis of asialoglycoprotein-enzyme conjugates by hepatocytes. Lab Invest (1980) 1.42
Collagen chain mRNAs in isolated heart cells from young and adult rats. J Mol Cell Cardiol (1988) 1.41
Menkes' disease: a disorder of zinc metabolism? Lancet (1989) 1.38
The role of radiocopper in the diagnosis of Wilson's disease. Gastroenterology (1979) 1.37
Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum Mol Genet (1999) 1.36
Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation. Cell Death Differ (2013) 1.36
Changes in the distribution of hepatic copper in relation to the progression of Wilson's disease (hepatolenticular degeneration). Am J Pathol (1968) 1.33
Ito-cell gene expression and collagen regulation. Hepatology (1990) 1.32
Evolution of the hepatic lesion in Wilson's disease (hepatolenticular degeneration). Prog Liver Dis (1972) 1.30
IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci U S A (1982) 1.29
Microtubule and motor-dependent endocytic vesicle sorting in vitro. J Cell Biol (2000) 1.26
Elastosis perforans serpiginosa during penicillamine therapy for Wilson disease. Arch Dermatol (1973) 1.26
Differential effects of gamma-interferon on collagen and fibronectin gene expression. J Biol Chem (1987) 1.26
Liver transplantation for Wilson's disease: indications and outcome. Hepatology (1994) 1.24
The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease. N Engl J Med (1987) 1.23
Mammalian hepatic lectin. Science (1974) 1.23
A role for microtubules in sorting endocytic vesicles in rat hepatocytes. Proc Natl Acad Sci U S A (1992) 1.21
Immunocytochemical localization of lysosomal beta-galactosidase in rat liver. J Cell Biol (1983) 1.21
Skeletal changes in Wilson's disease. A radiological study. Radiology (1970) 1.20
Measurement of gastrointestinal protein loss using ceruloplasmin labeled with copper. J Clin Invest (1967) 1.19
Localization of types I, III and IV collagen mRNAs in rat heart cells by in situ hybridization. J Mol Cell Cardiol (1989) 1.18
Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology (1995) 1.18
The significance of variations in the distribution of copper in liver disease. Am J Pathol (1980) 1.17
Clinical, morphologic, and chemical studies on copper toxicosis of Bedlington Terriers. J Am Vet Med Assoc (1979) 1.16
Cytoplasmic copper and its toxic effects. Studies in Indian childhood cirrhosis. Lancet (1979) 1.16
The effects of dexamethasone on in vitro collagen gene expression. J Biol Chem (1987) 1.15
Interaction of the microtubule cytoskeleton with endocytic vesicles and cytoplasmic dynein in cultured rat hepatocytes. J Biol Chem (1995) 1.14
Influence of cytosolic pH on receptor-mediated endocytosis of asialoorosomucoid. Am J Physiol (1988) 1.12
Ito cell expression of a nuclear retinoic acid receptor. Hepatology (1992) 1.12
Transcriptional switch from albumin to alpha-fetoprotein and changes in transcription of other genes during carbon tetrachloride induced liver regeneration. Biochemistry (1986) 1.11
TNF-alpha modulates expression of the tissue transglutaminase gene in liver cells. Am J Physiol (1998) 1.11
A membrane receptor protein for asialoglycoproteins. Methods Enzymol (1974) 1.11
Immunocytochemical localization of epoxide hydrase in hyperplastic nodules induced in rat liver by 2-acetylaminofluorene. Proc Natl Acad Sci U S A (1979) 1.10
Inhibition of c-Myc expression sensitizes hepatocytes to tumor necrosis factor-induced apoptosis and necrosis. J Biol Chem (2000) 1.09
Functional segregation of hepatic receptors for asialoglycoproteins during endocytosis. J Biol Chem (1980) 1.09
The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J Gen Virol (1994) 1.09
Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration). Gastroenterology (1973) 1.08
Fish oil, alcohol, and liver pathology: role of cytochrome P450 2E1. Proc Soc Exp Biol Med (1994) 1.08
Secretion, surface localization, turnover, and steady state expression of protein disulfide isomerase in rat hepatocytes. J Biol Chem (1995) 1.08
Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation (2001) 1.08
Hepatocytes sensitized to tumor necrosis factor-alpha cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways. J Biol Chem (2000) 1.07
Eight closely linked loci place the Wilson disease locus within 13q14-q21. Am J Hum Genet (1988) 1.07
Mitochondrial and fatty changes in hepatocytes of patients with Wilson's disease. Gastroenterology (1968) 1.07
Diagnosis of Wilson's disease. Gastroenterology (1978) 1.06
Morphologic and chemical studies on a murine mutation (toxic milk mice) resulting in hepatic copper toxicosis. Lab Invest (1988) 1.06
Three-dimensional organization of rat hepatocyte cytoskeleton: relation to the asialoglycoprotein endocytosis pathway. J Cell Sci (1996) 1.04
Development and use of a rat albumin cDNA clone to evaluate the effect of chronic ethanol administration on hepatic protein synthesis. Hepatology (1983) 1.02
Predictive testing for Wilson's disease using tightly linked and flanking DNA markers. Neurology (1991) 1.01
Wilson disease and idiopathic copper toxicosis. Am J Clin Nutr (1996) 1.00